Trump's New Drug Price Rule Is a Boon to Cannabis Stocks

The U.S. Department of Health & Human Services (HHS) just finalized its rules requiring pharmaceutical companies to list drug prices in their TV ads this summer. It's a huge catalyst for cannabis stocks going toe to toe with Big Pharma. One cannabis stock in particular is already expecting more than 200% sales growth this year, but its gains from this new executive order could be unheard of. Read more here... Tags: marijuana stocks To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and visitors become smarter, more confident investors. Disclaimer: © 2019 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Trump's New Drug Price Rule Is a Boon to Cannabis Stocks appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.